437.78
Schlusskurs vom Vortag:
$447.92
Offen:
$448.11
24-Stunden-Volumen:
508.33K
Relative Volume:
1.07
Marktkapitalisierung:
$12.30B
Einnahmen:
$2.16B
Nettoeinkommen (Verlust:
$416.39M
KGV:
33.42
EPS:
13.1
Netto-Cashflow:
$540.93M
1W Leistung:
+0.08%
1M Leistung:
+40.91%
6M Leistung:
+25.07%
1J Leistung:
+15.74%
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Vergleichen Sie MEDP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MEDP
Medpace Holdings Inc
|
437.78 | 12.58B | 2.16B | 416.39M | 540.93M | 13.10 |
![]()
TMO
Thermo Fisher Scientific Inc
|
477.28 | 182.01B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
203.99 | 148.12B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
572.09 | 46.09B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
118.05 | 34.04B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.54 | 33.07B | 15.50B | 1.33B | 2.16B | 7.34 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-29 | Herabstufung | UBS | Neutral → Sell |
2025-07-23 | Herabstufung | TD Cowen | Hold → Sell |
2025-06-24 | Eingeleitet | Barclays | Equal Weight |
2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
2024-09-27 | Herabstufung | UBS | Buy → Neutral |
2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
2024-08-01 | Eingeleitet | Truist | Hold |
2024-05-29 | Eingeleitet | TD Cowen | Buy |
2024-05-28 | Eingeleitet | Mizuho | Buy |
2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
2024-02-15 | Hochstufung | UBS | Neutral → Buy |
2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
2022-10-27 | Hochstufung | UBS | Sell → Neutral |
2022-09-07 | Eingeleitet | UBS | Sell |
2022-05-24 | Eingeleitet | Guggenheim | Neutral |
2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
2020-10-02 | Hochstufung | Truist | Hold → Buy |
2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
2018-09-17 | Eingeleitet | SunTrust | Hold |
2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Should I hold or sell Medpace Holdings Inc. stock in 2025Chart Pattern Recommendation For Smart Trading - jammulinksnews.com
How does Medpace Holdings Inc. generate profit in a changing economyChart Pattern Planner With Low Risk - jammulinksnews.com
How Medpace Holdings Inc. stock performs during market volatilityShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Institutional Tools Highlight Unusual Flow in Medpace Holdings Inc.Swing Trading Plan With Smart Signals in Review - metal.it
Medpace general counsel Ewald sells $1.35m in stock - Investing.com
Medpace general counsel Ewald sells $1.35m in stock By Investing.com - Investing.com Nigeria
Insider Selling at Medpace Holdings: Distinguishing Routine Moves from Red Flags - AInvest
Medpace stock slips as UBS cuts to Sell (MEDP:NASDAQ) - Seeking Alpha
Why Medpace (MEDP) Stock Is Trading Lower Today - TradingView
What makes Medpace Holdings Inc. stock price move sharplyCommunity Shared Smart Money Signals Show Movement - metal.it
Medpace stock rating downgraded to Sell by UBS on ambitious targets - Investing.com
Decoding Insider Selling at Medpace Holdings: A Strategic Investment Analysis - AInvest
North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace - Yahoo Finance
What Makes Medpace (MEDP) a New Strong Buy Stock - sharewise.com
Best Momentum Stocks to Buy for July 28th - TradingView
Is Medpace Holdings Inc. stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com
New Strong Buy Stocks for July 28th - TradingView
Why is Medpace Holdings Inc. stock attracting strong analyst attentionBest Dividend Forecasts To Watch Now - jammulinksnews.com
Medpace Holdings, Inc. Reports Strong Q2 Earnings and Market ResponseNews and Statistics - IndexBox
Top 10 Large Cap Gainers Last Week: Medpace, Baker Hughes, and More - AInvest
5 Revealing Analyst Questions From Medpace’s Q2 Earnings Call - FinancialContent
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga
Why Medpace Holdings Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - metal.it
Mizuho Securities Maintains Buy Rating on Medpace Holdings with $510 Price Target. - AInvest
Medpace Is Expanding Decentralized Clinical Trials & Improving Global Trial Capabilities But Is It ENOUGH? - Smartkarma
Medpace Holdings, Inc. (MEDP): A Bull Case Theory - Insider Monkey
Medpace Holdings, Inc. shares rise 1.01% after-hours after reporting numbers well above expectations. - AInvest
What drives Medpace Holdings Inc. stock priceOutstanding capital returns - PrintWeekIndia
Medpace Holdings (MEDP) Receives Price Target Boost from Mizuho | MEDP Stock News - GuruFocus
Medpace (MEDP) Target Price Boosted by Mizuho to $510 | MEDP Sto - GuruFocus
Stocks making big moves this week: Cal-Maine, Skillz, TransUnion, Medpace, and Bruker - Yahoo Finance
What analysts say about Medpace Holdings Inc. stockOutstanding growth strategies - Autocar Professional
Medpace Holdings Trading Volume Plummets 49.44 Percent to 285th Position Despite 4.18 Percent Stock Price Increase - AInvest
Medpace Holdings, Inc. Beat Revenue Forecasts By 12%: Here's What Analysts Are Forecasting Next - 富途牛牛
Medpace Holdings Reports Strong Q2 2025 Growth - The Globe and Mail
Medpace Holdings Plummets to 140th in Trading Volume Ranking Amid 61.52% Decline - AInvest
Medpace raises 2025 revenue guidance to $2.42B–$2.52B amid strong backlog conversion and lower cancellations - MSN
Medpace Stock Downgraded by TD Cowen After Significant RallyNews and Statistics - IndexBox
UBS Sticks to Its Hold Rating for Medpace Holdings (MEDP) - The Globe and Mail
Medpace (MEDP) Stock Trades Down, Here Is Why - Yahoo Finance
MEDP: Truist Securities Raises Medpace Holdings Price Target to - GuruFocus
Why Medpace Holdings Shares Are Facing Turbulence - TipRanks
Narrow-Moat Medpace Benefits From Rising Outsourcing Demand and Shift Toward Faster-Burning Studies - Morningstar
Baird Raises Price Target for Medpace Holdings (MEDP) to $490 | - GuruFocus
Barclays Raises Price Target for Medpace Holdings (MEDP) to $450 - GuruFocus
Medpace Holdings: Baird maintains a 'Neutral' Rating, The Target Price is $490 - AInvest
Medpace Holdings' (MEDP) 50% Stock Surge: A Deep Dive into Q2 Earnings and Strategic Growth Drivers - AInvest
Stocks making big moves yesterday: Vital Farms, Robinhood, Simmons First National, Medpace, and Azenta - Yahoo Finance
Truist Increases Price Target for Medpace (MEDP) to $436 | MEDP Stock News - GuruFocus
MEDP: TD Cowen Downgrades Medpace Holdings with PT Raise to $366 - GuruFocus
Medpace Holdings, Inc.'s (NASDAQ:MEDP) 54% Price Boost Is Out Of Tune With Earnings - 富途牛牛
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):